Please note that the copy function is not enabled for this field.
If you wish to
modify
existing outcomes, please copy and paste the current outcome text into the Update field.
LOGIN
CREATE ACCOUNT
LOGIN
CREATE ACCOUNT
MY TRIALS
REGISTER TRIAL
FAQs
HINTS AND TIPS
DEFINITIONS
Trial Review
The ANZCTR website will be unavailable from 1pm until 3pm (AEDT) on Wednesday the 30th of October for website maintenance. Please be sure to log out of the system in order to avoid any loss of data.
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been endorsed by the ANZCTR. Before participating in a study, talk to your health care provider and refer to this
information for consumers
Download to PDF
Trial details imported from ClinicalTrials.gov
For full trial details, please see the original record at
https://clinicaltrials.gov/study/NCT01585753
Registration number
NCT01585753
Ethics application status
Date submitted
25/04/2012
Date registered
26/04/2012
Date last updated
20/01/2016
Titles & IDs
Public title
MARCH Vascular Endothelium Substudy
Query!
Scientific title
Maraviroc Switch Vascular Endothelium (VE) Substudy: a Substudy of MARCH
Query!
Secondary ID [1]
0
0
MARCH-Kirby VE substudy
Query!
Universal Trial Number (UTN)
Query!
Trial acronym
MARCH VE
Query!
Linked study record
Query!
Health condition
Health condition(s) or problem(s) studied:
Cardiovascular Disease
0
0
Query!
Condition category
Condition code
Intervention/exposure
Study type
Observational
Query!
Patient registry
Query!
Target follow-up duration
Query!
Target follow-up type
Query!
Description of intervention(s) / exposure
Treatment: Drugs - NRTI + PI
Treatment: Drugs - maraviroc + PI
Treatment: Drugs - maraviroc + NRTI
Arm 1 - NRTI and PI
Arm 2 - Maraviroc + PI
Arm 3 - maraviroc + NRTI
Treatment: Drugs: NRTI + PI
tenofovir zidovudine abacavir lamivudine emtricitabine ritonavir darunavir atazanavir lopinavir fosamprenavir
Treatment: Drugs: maraviroc + PI
maraviroc ritonavir darunavir atazanavir lopinavir fosamprenavir
Treatment: Drugs: maraviroc + NRTI
maraviroc tenofovir zidovudine abacavir lamivudine emtricitabine
Query!
Intervention code [1]
0
0
Treatment: Drugs
Query!
Comparator / control treatment
Query!
Control group
Query!
Outcomes
Primary outcome [1]
0
0
Mean change in small arterial elasticity (SAE) as measure by pulse wave tonometry
Query!
Assessment method [1]
0
0
measured at 6 timepoints week 0, 4, 12, 24, 48, 96
Query!
Timepoint [1]
0
0
96 weeks
Query!
Secondary outcome [1]
0
0
• Mean change in large arterial elasticity (LAE) as measure by pulse wave tonometry
Query!
Assessment method [1]
0
0
measured at 6 timepoints, week 0,4,12,24,48,96
Query!
Timepoint [1]
0
0
96 weeks
Query!
Secondary outcome [2]
0
0
• Changes from baseline in selected soluble markers of immune activation, coagulation, vascular and platelet function
Query!
Assessment method [2]
0
0
stored bloods from the main study will be used to explore changes in vascular biomarkers
Query!
Timepoint [2]
0
0
96 weeks
Query!
Eligibility
Key inclusion criteria
* Enrolled prior to treatment in the parent study;
* Provision of written, informed consent for participation in the substudy
Query!
Minimum age
18
Years
Query!
Query!
Maximum age
No limit
Query!
Query!
Sex
Both males and females
Query!
Can healthy volunteers participate?
No
Query!
Key exclusion criteria
* Known supraventricular tachycardia such as atrial flutter and/or fibrillation that precludes the measurement of pulse wave using tonometry.
Query!
Study design
Purpose
Query!
Duration
Query!
Selection
Query!
Timing
Prospective
Query!
Statistical methods / analysis
Query!
Recruitment
Recruitment status
Completed
Query!
Data analysis
Query!
Reason for early stopping/withdrawal
Query!
Other reasons
Query!
Date of first participant enrolment
Anticipated
Query!
Actual
1/06/2012
Query!
Date of last participant enrolment
Anticipated
Query!
Actual
Query!
Date of last data collection
Anticipated
Query!
Actual
1/12/2015
Query!
Sample size
Target
Query!
Accrual to date
Query!
Final
34
Query!
Recruitment in Australia
Recruitment state(s)
NSW
Query!
Recruitment hospital [1]
0
0
St. Vincent's Hospital - Sydney
Query!
Recruitment postcode(s) [1]
0
0
2010 - Sydney
Query!
Recruitment outside Australia
Country [1]
0
0
Argentina
Query!
State/province [1]
0
0
Buenos Aires
Query!
Country [2]
0
0
Germany
Query!
State/province [2]
0
0
Frankfurt am Main
Query!
Country [3]
0
0
Thailand
Query!
State/province [3]
0
0
Bangkok
Query!
Funding & Sponsors
Primary sponsor type
Government body
Query!
Name
Kirby Institute
Query!
Address
Query!
Country
Query!
Ethics approval
Ethics application status
Query!
Summary
Brief summary
This is a substudy of MARCH, in which we are exploring the changes in the vascular endothelium using pulse wave tonometry (a non invasive measure of cardiac health) to measure the changes in small and large arterial elasticity in participants of the MARCH study who switch to maraviroc-based regimens over 96 weeks of follow-up.
Query!
Trial website
https://clinicaltrials.gov/study/NCT01585753
Query!
Trial related presentations / publications
Query!
Public notes
Query!
Contacts
Principal investigator
Name
0
0
Sarah L Pett, FRACP,FRCPE,PhD
Query!
Address
0
0
Kirby Institute, UNSW
Query!
Country
0
0
Query!
Phone
0
0
Query!
Fax
0
0
Query!
Email
0
0
Query!
Contact person for public queries
Name
0
0
Query!
Address
0
0
Query!
Country
0
0
Query!
Phone
0
0
Query!
Fax
0
0
Query!
Email
0
0
Query!
Contact person for scientific queries
No information has been provided regarding IPD availability
What supporting documents are/will be available?
No Supporting Document Provided
Results publications and other study-related documents
No documents have been uploaded by study researchers.
Results not provided in
https://clinicaltrials.gov/study/NCT01585753
Download to PDF